GoldbergAIDunlayMCSweetCS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol1995;75: 793–5.
2.
SaineDRAhrensER. Renal impairment associated with losartan (letter). Ann Intern Med1996;124:775.
3.
AhmadS. Losartan and severe migraine. JAMA1995;274: 1266–7.
4.
NygaardBStrandgaardS. Marked hepatotoxicity associated with losartan treatment. Blood Press1996;5: 190–1.
5.
GradmanAHArcuriKEGoldbergAIIkedaLSNelsonEBSnavelyDBA randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension1995;25:1345–50.
